ZR MedTech

ZR MedTech is a high-tech enterprise dedicated to the research, development, and application of new biomaterials in regenerative medicine. It holds exclusive advanced core technology for basement membrane biomaterials in China. The company has built modern regenerative medicine R&D centers in Shanghai and Taicang, and owns China’s largest production base for extracellular matrix raw materials, as well as automated production lines and testing laboratories. ZR MedTech has developed over 20 Class III implantable medical device products based on its basement membrane platform technology, covering applications in hernia and abdominal wall surgery, neurosurgery, dermatology, gynecology, otorhinolaryngology, and orthopedics. Among these, the AnTisheng biological hernia mesh and AnRuSheng dura mater (spinal) patch have been successively approved for marketing. The company has obtained two National Innovative Medical Device Approvals, and has been recognized as a National High-Tech Enterprise, a Jiangsu Province Potential Unicorn Enterprise, and a Jiangsu Province Double Innovation Talent Enterprise. It has applied for or been granted 36 national invention patents and five international patents, and has undertaken research projects including sub-projects under the National Natural Science Foundation of China, National Defense Technology, and the National Key Research and Development Program.